Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats.
Animals
Colitis
/ chemically induced
Cyclooxygenase 2
/ metabolism
Disease Models, Animal
Interleukin-1beta
/ metabolism
Magnetic Resonance Imaging
/ methods
Male
Mice
Nitric Oxide Synthase Type II
/ metabolism
Random Allocation
Rats
Rats, Sprague-Dawley
Trinitrobenzenesulfonic Acid
/ adverse effects
Tumor Necrosis Factor-alpha
/ metabolism
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
07
2021
accepted:
14
10
2021
entrez:
4
11
2021
pubmed:
5
11
2021
medline:
24
12
2021
Statut:
epublish
Résumé
Pre-pubertal murine models of acute colitis are lacking. Magnetic resonance colonography (MRC) is a promising minimally invasive tool to assess colitis. We aimed to: 1/ Adapt a model of acute experimental colitis to pre-pubertal rats and determine whether MRC characteristics correlate with histological inflammation. 2/ Test this model by administering a diet supplemented in transforming growth factor β2 to reverse inflammation. Twenty-four rats were randomized at weaning to one of 3 groups: Trinitrobenzene Sulfonic Acid (TNBS) group (n = 8) fed a standard diet, that received an intra-rectal 60 mg/kg dose of TNBS-ethanol; Control group (n = 8) fed standard diet, that received a dose of intra-rectal PBS; TNBS+MODULEN group (n = 8) that received a dose of TNBS and were exclusively fed MODULEN-IBD® after induction of colitis. One week after induction of colitis, rats were assessed by MRC, colon histopathology and inflammation markers (Interleukin 1β, Tumor necrosis factor α, Nitric Oxide Synthase 2 and Cyclooxygenase 2). TNBS induced typical features of acute colitis on histopathology and MRC (increased colon wall thickness, increased colon intensity on T2-weighted images, target sign, ulcers). Treatment with MODULEN-IBD® did not reduce signs of colitis on MRC. Inflammatory marker expression did not differ among study groups.
Identifiants
pubmed: 34735489
doi: 10.1371/journal.pone.0259135
pii: PONE-D-21-22589
pmc: PMC8568272
doi:
Substances chimiques
Interleukin-1beta
0
Tumor Necrosis Factor-alpha
0
Trinitrobenzenesulfonic Acid
8T3HQG2ZC4
Nitric Oxide Synthase Type II
EC 1.14.13.39
Cyclooxygenase 2
EC 1.14.99.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259135Déclaration de conflit d'intérêts
No authors have competing interests.
Références
Am J Gastroenterol. 2018 Feb;113(2):265-272
pubmed: 28809388
J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):481-6
pubmed: 14508220
PLoS One. 2014 Jul 07;9(7):e100921
pubmed: 25000184
J Crohns Colitis. 2019 Jul 25;13(7):846-855
pubmed: 30541015
Nutrients. 2020 Mar 20;12(3):
pubmed: 32245085
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Inflamm Bowel Dis. 2012 Oct;18(10):1940-9
pubmed: 22262626
Inflamm Bowel Dis. 2010 Jun;16(6):953-61
pubmed: 19834970
J Immunol Res. 2019 Dec 1;2019:7247238
pubmed: 31886308
Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G692-G700
pubmed: 30735453
Scand J Gastroenterol. 2017 Jan;52(1):5-10
pubmed: 27553420
J Crohns Colitis. 2020 Oct 07;:
pubmed: 33026087
Curr Protoc Mouse Biol. 2017 Mar 2;7(1):13-28
pubmed: 28252200
Aliment Pharmacol Ther. 2000 Mar;14(3):281-9
pubmed: 10735920
J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):240-50
pubmed: 20118800
Int Rev Immunol. 2000;19(1):51-62
pubmed: 10723677
Inflamm Bowel Dis. 2015 Jun;21(6):1248-59
pubmed: 25989337
Dig Liver Dis. 2019 Apr;51(4):496-502
pubmed: 30611597
Aliment Pharmacol Ther. 1994 Dec;8(6):609-15
pubmed: 7696450
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1232-1241
pubmed: 30345577
Inflammopharmacology. 2016 Jun;24(2-3):109-18
pubmed: 27038922
Inflamm Bowel Dis. 2013 Feb;19(2):378-85
pubmed: 22573581
Gastroenterology. 2003 Dec;125(6):1750-61
pubmed: 14724828
World J Gastroenterol. 2018 Jul 7;24(25):2741-2763
pubmed: 29991879
Pharmacol Res. 2019 Mar;141:591-601
pubmed: 30711419
Ann Med Surg (Lond). 2016 Aug 19;11:9-15
pubmed: 27656280
Isr Med Assoc J. 2008 Jul;10(7):503-7
pubmed: 18751627
Dig Dis Sci. 2005 Jan;50(1):143-150
pubmed: 27837390
Gastroenterology. 1989 Mar;96(3):795-803
pubmed: 2914642
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
Mediators Inflamm. 2018 Feb 15;2018:8430614
pubmed: 29670469
J Nutr Biochem. 2013 Apr;24(4):700-5
pubmed: 22841543
Gut. 2000 May;46(5):694-700
pubmed: 10764714
PLoS One. 2013;8(1):e54543
pubmed: 23382912
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
World J Gastroenterol. 2017 Sep 7;23(33):6016-6029
pubmed: 28970718